Adamas Pharma's Gocovri Approved, A Welcome Addition To Parkinson's Treatments
August 25, 2017 at 12:03 PM EDT
Adamas Pharmaceuticals Inc (NASDAQ: ADMS) shares were on a tear Friday following
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.